41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
6866569
656531
1
Create a timeline
Public Timelines
For companies For educational institutions For teachers For students Dashboard
For educational institutions For teachers For students Dashboard
FAQ
Create a timeline
Public timelines
FAQ
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate

jan 1, 1998 - Trastuzumab

Description:

FDA approves trastuzumab, a monoclonal antibody that targets cancer cells that overexpress the HER2 gene, for the treatment of women with HER2-positive metastatic breast cancer. Trastuzumab is later approved for the adjuvant (post-operative) treatment of women with HER2-positive early-stage breast cancer.

Added to timeline:

Milestones in Cancer Research and Discovery

BySam
14 Jun 2022
1
0
284

Date:

jan 1, 1998
Now
~ 28 years ago
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL